JP2018513679A5 - - Google Patents

Download PDF

Info

Publication number
JP2018513679A5
JP2018513679A5 JP2017549623A JP2017549623A JP2018513679A5 JP 2018513679 A5 JP2018513679 A5 JP 2018513679A5 JP 2017549623 A JP2017549623 A JP 2017549623A JP 2017549623 A JP2017549623 A JP 2017549623A JP 2018513679 A5 JP2018513679 A5 JP 2018513679A5
Authority
JP
Japan
Prior art keywords
cancer
cdna
ctcs
droplet
ctc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549623A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018513679A (ja
JP7144934B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/024367 external-priority patent/WO2016154600A1/en
Publication of JP2018513679A publication Critical patent/JP2018513679A/ja
Publication of JP2018513679A5 publication Critical patent/JP2018513679A5/ja
Application granted granted Critical
Publication of JP7144934B2 publication Critical patent/JP7144934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549623A 2015-03-25 2016-03-25 血液試料中の循環腫瘍細胞のデジタル分析 Active JP7144934B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562137891P 2015-03-25 2015-03-25
US62/137,891 2015-03-25
US201562219339P 2015-09-16 2015-09-16
US62/219,339 2015-09-16
US201562253619P 2015-11-10 2015-11-10
US62/253,619 2015-11-10
PCT/US2016/024367 WO2016154600A1 (en) 2015-03-25 2016-03-25 Digital analysis of circulating tumor cells in blood samples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021012116A Division JP7203128B2 (ja) 2015-03-25 2021-01-28 血液試料中の循環腫瘍細胞のデジタル分析

Publications (3)

Publication Number Publication Date
JP2018513679A JP2018513679A (ja) 2018-05-31
JP2018513679A5 true JP2018513679A5 (https=) 2019-05-09
JP7144934B2 JP7144934B2 (ja) 2022-09-30

Family

ID=56977798

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017549623A Active JP7144934B2 (ja) 2015-03-25 2016-03-25 血液試料中の循環腫瘍細胞のデジタル分析
JP2021012116A Active JP7203128B2 (ja) 2015-03-25 2021-01-28 血液試料中の循環腫瘍細胞のデジタル分析

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021012116A Active JP7203128B2 (ja) 2015-03-25 2021-01-28 血液試料中の循環腫瘍細胞のデジタル分析

Country Status (9)

Country Link
US (3) US20180057889A1 (https=)
EP (1) EP3274476B1 (https=)
JP (2) JP7144934B2 (https=)
KR (1) KR102502087B1 (https=)
CN (1) CN107614698A (https=)
AU (2) AU2016238253B2 (https=)
ES (1) ES2954456T3 (https=)
IL (1) IL254639B (https=)
WO (1) WO2016154600A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4361609A3 (en) 2012-02-03 2024-07-17 California Institute of Technology Signal encoding and decoding in multiplexed biochemical assays
AU2016238253B2 (en) 2015-03-25 2022-06-16 The General Hospital Corporation Digital analysis of circulating tumor cells in blood samples
CN110050075B (zh) * 2016-10-27 2024-04-02 通用医疗公司 用于确定特定癌症的癌症疗法的功效的血液样品的数字分析
US20180252722A1 (en) * 2017-03-05 2018-09-06 Yan Wang PCR-based Method for Counting Circulating Tumor Cells
WO2019092213A1 (en) * 2017-11-09 2019-05-16 Biomillenia Sas Microbial selection system
WO2019165242A1 (en) * 2018-02-23 2019-08-29 Paraskevi Giannakakou Assay for detection of androgen receptor variants
CN108535145A (zh) * 2018-03-09 2018-09-14 深圳市瑞图生物技术有限公司 快速检测外周血液中网织红细胞数量的方法及装置
CN112424377A (zh) 2018-04-17 2021-02-26 克罗玛科德公司 用于多重分析的方法和系统
CN110456034B (zh) * 2018-05-07 2022-07-22 上海市第十人民医院 一种循环肿瘤细胞的检测方法
EP3814775A4 (en) 2018-06-29 2021-09-01 The General Hospital Corporation ISOLATION AND ANALYSIS OF CELLS AND RARE PARTICLES DERIVED FROM THE BRAIN
US12203129B2 (en) * 2018-07-03 2025-01-21 ChromaCode, Inc. Formulations and signal encoding and decoding methods for massively multiplexed biochemical assays
KR20210057765A (ko) * 2018-09-11 2021-05-21 더 제너럴 하스피탈 코포레이션 간 질환을 검출하는 방법
KR102380529B1 (ko) * 2020-04-29 2022-03-31 인제대학교 산학협력단 전이성 전립선 암의 진단 및 예후 예측을 위한 혈중종양세포 기반 바이오 마커 조성물
CN112662774A (zh) * 2021-01-12 2021-04-16 南方医科大学南方医院 一种肝癌循环肿瘤细胞标志物及其应用
EP4301499A4 (en) 2021-03-05 2025-01-22 Enumerix, Inc. SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSES
CN114395622A (zh) * 2021-12-13 2022-04-26 深圳先进技术研究院 一种利用数字pcr检测循环肿瘤细胞egfr基因突变的方法及其应用
DE102022211089A1 (de) * 2022-10-19 2024-04-25 Robert Bosch Gesellschaft mit beschränkter Haftung Kombinierte Zellspezifische Markierung und Anreicherung von Biomarkern

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535A (en) 1851-11-18 Stove-geate
US889A (en) 1838-08-20 Mode of constructing metal bench-vises
DE29623597U1 (de) 1996-11-08 1999-01-07 Eppendorf - Netheler - Hinz Gmbh, 22339 Hamburg Temperierblock mit Temperiereinrichtungen
US20080050393A1 (en) 1998-12-03 2008-02-28 Tang Y Tom Novel nucleic acids and polypeptides
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
CA2417866A1 (en) * 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030143539A1 (en) 2000-12-08 2003-07-31 Francois Bertucci Gene expression profiling of primary breast carcinomas using arrays of candidate genes
JP2005512510A (ja) 2001-05-16 2005-05-12 ノバルティス アクチエンゲゼルシャフト 予後および治療標的として乳癌で発現される遺伝子
US20030073623A1 (en) 2001-07-30 2003-04-17 Drmanac Radoje T. Novel nucleic acid sequences obtained from various cDNA libraries
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20060275794A1 (en) 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20090118175A1 (en) 2005-05-06 2009-05-07 Macina Roberto A Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer
CA2652052A1 (en) * 2006-05-16 2007-11-29 Nugen Technologies, Inc. Nucleic acid separation and purification method based on reversible charge interactions
EP2589668A1 (en) * 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
WO2009051734A1 (en) * 2007-10-17 2009-04-23 The General Hospital Corporation Microchip-based devices for capturing circulating tumor cells and methods of their use
US9068181B2 (en) 2008-05-23 2015-06-30 The General Hospital Corporation Microfluidic droplet encapsulation
US20120252015A1 (en) * 2011-02-18 2012-10-04 Bio-Rad Laboratories Methods and compositions for detecting genetic material
US9625454B2 (en) * 2009-09-04 2017-04-18 The Research Foundation For The State University Of New York Rapid and continuous analyte processing in droplet microfluidic devices
US20110166030A1 (en) * 2009-09-30 2011-07-07 Yixin Wang Prediction of response to docetaxel therapy based on the presence of TMPRSSG2:ERG fusion in circulating tumor cells
CA2789425C (en) 2010-02-12 2020-04-28 Raindance Technologies, Inc. Digital analyte analysis with polymerase error correction
US20120329061A1 (en) * 2010-03-11 2012-12-27 Board Of Regents, The University Of Texas System Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of cancer patients
AU2015268617A1 (en) 2010-03-31 2016-01-07 Sividon Diagnostics Gmbh Method for breast cancer recurrence prediction under endocrine treatment
ES2525382T3 (es) 2010-03-31 2014-12-23 Sividon Diagnostics Gmbh Método para la predicción de recurrencia del cáncer de mama bajo tratamiento endocrino
US9650629B2 (en) * 2010-07-07 2017-05-16 Roche Molecular Systems, Inc. Clonal pre-amplification in emulsion
JP2013540995A (ja) 2010-08-18 2013-11-07 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 疾患に対する循環バイオマーカー
WO2012115885A1 (en) 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
WO2012135397A2 (en) 2011-03-29 2012-10-04 Lisanti Michael P Lactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
GB2510539B (en) 2011-10-24 2016-04-20 Gen Hospital Corp Biomarkers of cancer
US9766244B2 (en) 2012-07-02 2017-09-19 The General Hospital Corporation Diagnosis and monitoring treatment of prostate cancer
AU2013302867A1 (en) * 2012-08-13 2015-02-26 The Regents Of The University Of California Methods and systems for detecting biological components
CA2884820A1 (en) 2012-09-14 2014-03-20 Memorial Sloan-Kettering Cancer Center Genes associated with dasatinib sensitivity
US9671405B2 (en) 2012-09-19 2017-06-06 Cornell University Identifying taxane sensitivity in prostate cancer patients
US20140154681A1 (en) 2012-11-12 2014-06-05 Nanostring Technologies, Inc. Methods to Predict Breast Cancer Outcome
WO2014165762A1 (en) 2013-04-05 2014-10-09 Raindance Technologies, Inc. Rare cell analysis after negative selection
CA2920317A1 (en) 2013-08-12 2015-02-19 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
EP3058316B1 (en) 2013-10-18 2019-03-13 The General Hospital Corporation Microfluidic sorting using high gradient magnetic fields
CA2941161A1 (en) 2014-03-13 2015-09-17 F.Hoffmann-La Roche Ag Methods and compositions for modulating estrogen receptor mutants
MA40271A (fr) 2014-05-21 2017-03-29 Hoffmann La Roche Procédés pour traiter le cancer du sein luminal a pr-positif, avec un inhibiteur de pi3k, pictilisib
DK3230736T3 (da) 2014-12-12 2020-06-08 Celcuity Inc Fremgangsmåder til måling af ErbB-signaleringsvejsaktivitet til at diagnosticere og behandle cancerpatienter
EP3259375B1 (en) 2015-02-20 2019-01-09 Comelz S.p.a. Method for cutting natural hides
US20160304962A1 (en) 2015-03-12 2016-10-20 Janssen Pharmaceutica Nv WHOLE BLOOD BASED mRNA MARKERS FOR PREDICTING PROSTATE CANCER AND METHODS OF DETECTING THE SAME
AU2016238253B2 (en) 2015-03-25 2022-06-16 The General Hospital Corporation Digital analysis of circulating tumor cells in blood samples
CN110050075B (zh) 2016-10-27 2024-04-02 通用医疗公司 用于确定特定癌症的癌症疗法的功效的血液样品的数字分析

Similar Documents

Publication Publication Date Title
JP2018513679A5 (https=)
Heredia-Soto et al. Liquid biopsy in pancreatic cancer: are we ready to apply it in the clinical practice?
Ma et al. Liquid biopsy in cancer: current status, challenges and future prospects
Oshi et al. Urine as a source of liquid biopsy for cancer
Johansson et al. Considerations and quality controls when analyzing cell-free tumor DNA
Pardini et al. Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies
Nassar et al. Circulating miRNA as biomarkers for colorectal cancer diagnosis and liver metastasis
Wu et al. Current and developing liquid biopsy techniques for breast cancer
Daniel et al. A panel of MicroRNAs as diagnostic biomarkers for the identification of prostate cancer
JP2014516543A5 (https=)
Martinez-Dominguez et al. Current technologies for RNA-directed liquid diagnostics
US20150184248A1 (en) Method for detecting pancreatic cancer and detection kit
Munteanu et al. MiRNA-based inspired approach in diagnosis of prostate cancer
US10738360B2 (en) Method for assisting detection of alzheimer'S disease or mild cognitive impairment
Kim et al. Non-coding RNAs: functional aspects and diagnostic utility in oncology
Temilola et al. The prospect and challenges to the flow of liquid biopsy in Africa
JP2020501517A5 (https=)
Kan et al. Exploring the role of circulating cell-free RNA in the development of colorectal cancer
Wang et al. Molecular tracing of prostate cancer lethality
Hofmann et al. Telomere length varies by DNA extraction method: implications for epidemiologic research
Crocetto et al. Unlocking precision medicine: liquid biopsy advancements in renal cancer detection and monitoring
Rodriguez et al. Non-coding RNA signatures of B-cell acute lymphoblastic leukemia
Keup et al. Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patients
Chung et al. Recent technologies towards diagnostic and therapeutic applications of circulating nucleic acids in colorectal cancers
Garbo et al. Exploring the potential of non-coding RNAs as liquid biopsy biomarkers for lung cancer screening: a literature review